Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALGORAE PHARMACEUTICALS LIMITED Capital/Financing Update 2014

Dec 7, 2014

64249_rns_2014-12-07_aec5c1ff-98eb-448a-8ee0-d5d795e60834.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [122 x 70] intentionally omitted <==

Living Cell Technologies Limited

  • 8 December 2014

Company Announcements Office Australian Securities Exchange

Share Purchase Plan-Cleansing Notice

Pursuant to ASIC Class Order [CO 09/425], Living Cell Technologies Limited ("the Company") gives notice that:

  • a) The Company will issue shares under a Share Purchase Plan (SPP) without disclosure under Part 6D.2 of the Corporations Act 2001 (Cth) ( the "Corporations Act") as announced in its release dated 8 October 2014.

  • b) This notice is given in accordance with CO 09/425.

  • c) As at the date of the notice, the Company has complied with

    • i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company.

    • ii) Section 674 of the Corporations Act.

  • d) As at the date of the notice, there is no "excluded information" (as defined in subsection 708A(7) of the Corporations Act) which is required to be disclosed by the Company.

NJV Geddes

Company Secretary

Living Cell Technologies Limited